Alyssa Rose Letourneau, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dermatomyositis | 1 | 2017 | 224 | 0.500 |
Why?
|
Immunocompromised Host | 3 | 2017 | 847 | 0.460 |
Why?
|
Lung Diseases, Fungal | 1 | 2014 | 122 | 0.460 |
Why?
|
Opportunistic Infections | 2 | 2016 | 389 | 0.410 |
Why?
|
Cytomegalovirus Infections | 1 | 2017 | 820 | 0.380 |
Why?
|
Insurance Claim Review | 1 | 2013 | 720 | 0.330 |
Why?
|
Digestive System Surgical Procedures | 1 | 2013 | 576 | 0.320 |
Why?
|
Inappropriate Prescribing | 2 | 2021 | 202 | 0.320 |
Why?
|
Hysterectomy | 1 | 2013 | 927 | 0.300 |
Why?
|
Organ Transplantation | 3 | 2023 | 1139 | 0.270 |
Why?
|
Antifungal Agents | 2 | 2020 | 730 | 0.260 |
Why?
|
Surgical Wound Infection | 1 | 2013 | 1540 | 0.240 |
Why?
|
Population Surveillance | 1 | 2013 | 2616 | 0.220 |
Why?
|
Ceftriaxone | 1 | 2023 | 168 | 0.210 |
Why?
|
Pneumonia | 1 | 2014 | 2133 | 0.210 |
Why?
|
Postpartum Period | 1 | 2007 | 1086 | 0.190 |
Why?
|
Transplants | 1 | 2022 | 209 | 0.180 |
Why?
|
Fungemia | 1 | 2020 | 53 | 0.180 |
Why?
|
Lung | 2 | 2017 | 9856 | 0.170 |
Why?
|
Pneumonia, Viral | 1 | 2017 | 3240 | 0.170 |
Why?
|
Sepsis | 2 | 2023 | 2593 | 0.170 |
Why?
|
Cross Infection | 2 | 2020 | 1416 | 0.170 |
Why?
|
Disease Outbreaks | 2 | 2020 | 1772 | 0.160 |
Why?
|
Latent Tuberculosis | 1 | 2021 | 225 | 0.160 |
Why?
|
Subclavian Artery | 1 | 2017 | 130 | 0.140 |
Why?
|
Histoplasmosis | 1 | 2016 | 66 | 0.140 |
Why?
|
Anti-Bacterial Agents | 4 | 2023 | 7181 | 0.140 |
Why?
|
Takayasu Arteritis | 1 | 2017 | 96 | 0.130 |
Why?
|
Anti-Infective Agents | 1 | 2023 | 972 | 0.130 |
Why?
|
Diagnosis, Differential | 5 | 2017 | 12959 | 0.130 |
Why?
|
Listeriosis | 1 | 2016 | 149 | 0.130 |
Why?
|
Chorioamnionitis | 1 | 2016 | 155 | 0.130 |
Why?
|
Communicable Diseases | 1 | 2023 | 880 | 0.130 |
Why?
|
Muscle Weakness | 1 | 2017 | 413 | 0.120 |
Why?
|
Listeria monocytogenes | 1 | 2016 | 250 | 0.120 |
Why?
|
Bacterial Infections | 1 | 2022 | 1401 | 0.110 |
Why?
|
Outpatients | 1 | 2021 | 1486 | 0.110 |
Why?
|
Fever | 2 | 2017 | 1616 | 0.110 |
Why?
|
Infection Control | 2 | 2020 | 966 | 0.110 |
Why?
|
Arterial Occlusive Diseases | 1 | 2017 | 793 | 0.110 |
Why?
|
Health Records, Personal | 1 | 2013 | 124 | 0.110 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 1978 | 0.100 |
Why?
|
Hypotension | 1 | 2017 | 884 | 0.100 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2017 | 810 | 0.100 |
Why?
|
Smoking | 1 | 2007 | 8987 | 0.090 |
Why?
|
Dyspnea | 1 | 2017 | 1303 | 0.090 |
Why?
|
Antitubercular Agents | 1 | 2017 | 1320 | 0.080 |
Why?
|
Early Diagnosis | 1 | 2014 | 1184 | 0.080 |
Why?
|
Antiviral Agents | 1 | 2021 | 2987 | 0.080 |
Why?
|
Rectum | 1 | 2013 | 904 | 0.080 |
Why?
|
International Classification of Diseases | 1 | 2013 | 867 | 0.080 |
Why?
|
Bottle Feeding | 1 | 2007 | 66 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 1 | 2017 | 1790 | 0.080 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2020 | 2214 | 0.070 |
Why?
|
Breast | 1 | 2016 | 1969 | 0.070 |
Why?
|
Lung Diseases | 1 | 2017 | 1886 | 0.070 |
Why?
|
Connecticut | 1 | 2007 | 366 | 0.070 |
Why?
|
Intensive Care Units | 1 | 2020 | 3679 | 0.070 |
Why?
|
Patient Selection | 2 | 2021 | 4215 | 0.070 |
Why?
|
Mycobacterium tuberculosis | 1 | 2017 | 1832 | 0.070 |
Why?
|
Hospitals | 2 | 2020 | 3952 | 0.070 |
Why?
|
Bone Marrow Transplantation | 1 | 2014 | 2765 | 0.070 |
Why?
|
Infant Formula | 1 | 2007 | 199 | 0.070 |
Why?
|
Colon | 1 | 2013 | 1772 | 0.070 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2020 | 3523 | 0.060 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2016 | 2026 | 0.060 |
Why?
|
Health Services Accessibility | 1 | 2021 | 5137 | 0.060 |
Why?
|
Liver Neoplasms | 1 | 2020 | 4253 | 0.060 |
Why?
|
Humans | 21 | 2023 | 744343 | 0.060 |
Why?
|
Physicians | 1 | 2021 | 4567 | 0.050 |
Why?
|
Family Characteristics | 1 | 2007 | 1000 | 0.050 |
Why?
|
Cephalosporins | 1 | 2023 | 204 | 0.050 |
Why?
|
Female | 11 | 2022 | 380194 | 0.050 |
Why?
|
beta-Lactamases | 1 | 2023 | 306 | 0.050 |
Why?
|
Pilot Projects | 2 | 2020 | 8324 | 0.050 |
Why?
|
Insurance, Health | 1 | 2013 | 2494 | 0.050 |
Why?
|
Interviews as Topic | 1 | 2007 | 2539 | 0.050 |
Why?
|
Infusions, Parenteral | 1 | 2020 | 419 | 0.040 |
Why?
|
Educational Status | 1 | 2007 | 2540 | 0.040 |
Why?
|
Counseling | 1 | 2007 | 1523 | 0.040 |
Why?
|
Urban Population | 1 | 2007 | 2021 | 0.040 |
Why?
|
Retrospective Studies | 5 | 2022 | 77449 | 0.040 |
Why?
|
North America | 1 | 2022 | 1249 | 0.040 |
Why?
|
Middle Aged | 7 | 2022 | 213383 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2013 | 15076 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2017 | 20129 | 0.040 |
Why?
|
Microbial Sensitivity Tests | 1 | 2023 | 1877 | 0.040 |
Why?
|
Hemofiltration | 1 | 2017 | 57 | 0.040 |
Why?
|
Immunomodulation | 1 | 2021 | 541 | 0.040 |
Why?
|
Thrombocytosis | 1 | 2017 | 81 | 0.040 |
Why?
|
Drug Combinations | 1 | 2021 | 1959 | 0.030 |
Why?
|
Drug Resistance, Bacterial | 1 | 2023 | 1035 | 0.030 |
Why?
|
Erythema | 1 | 2017 | 257 | 0.030 |
Why?
|
Nephritis | 1 | 2016 | 159 | 0.030 |
Why?
|
Recurrence | 1 | 2007 | 8340 | 0.030 |
Why?
|
Pregnancy Trimester, Third | 1 | 2016 | 571 | 0.030 |
Why?
|
Male | 7 | 2022 | 350118 | 0.030 |
Why?
|
Nausea | 1 | 2016 | 673 | 0.030 |
Why?
|
Consensus | 1 | 2022 | 2959 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2020 | 2715 | 0.030 |
Why?
|
Cholestasis | 1 | 2016 | 378 | 0.030 |
Why?
|
Propensity Score | 1 | 2020 | 1781 | 0.030 |
Why?
|
Risk Assessment | 1 | 2014 | 23338 | 0.030 |
Why?
|
Stress, Psychological | 1 | 2007 | 4245 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2017 | 956 | 0.020 |
Why?
|
Travel | 1 | 2017 | 788 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 2017 | 1442 | 0.020 |
Why?
|
Adult | 5 | 2020 | 214055 | 0.020 |
Why?
|
Boston | 1 | 2022 | 9313 | 0.020 |
Why?
|
Skin Diseases | 1 | 2017 | 1065 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8663 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2021 | 3528 | 0.020 |
Why?
|
Renal Dialysis | 1 | 2017 | 1786 | 0.020 |
Why?
|
Anemia | 1 | 2017 | 1506 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2022 | 57776 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2007 | 39050 | 0.020 |
Why?
|
Infant | 1 | 2007 | 35136 | 0.020 |
Why?
|
Mass Screening | 1 | 2021 | 5255 | 0.020 |
Why?
|
Mammography | 1 | 2016 | 2476 | 0.020 |
Why?
|
Quality Improvement | 1 | 2020 | 3749 | 0.020 |
Why?
|
Radiography | 1 | 2016 | 7023 | 0.020 |
Why?
|
Critical Illness | 1 | 2017 | 2670 | 0.020 |
Why?
|
Aged | 3 | 2022 | 163280 | 0.010 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2016 | 2104 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2022 | 21746 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2020 | 4468 | 0.010 |
Why?
|
Prospective Studies | 1 | 2007 | 53288 | 0.010 |
Why?
|
Health Personnel | 1 | 2016 | 3218 | 0.010 |
Why?
|
Inflammation | 1 | 2022 | 10638 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 20947 | 0.010 |
Why?
|
Pain | 1 | 2016 | 4986 | 0.010 |
Why?
|
United States | 2 | 2020 | 69872 | 0.010 |
Why?
|
Hospitalization | 1 | 2020 | 10262 | 0.010 |
Why?
|
Adolescent | 1 | 2007 | 85781 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 40075 | 0.010 |
Why?
|
Pregnancy | 1 | 2016 | 29144 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 56430 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 72290 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2016 | 20822 | 0.010 |
Why?
|